Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01045343 · ClinicalTrials.gov registry record · NA
Feasibility Study of an Integrated Diagnostic System to Manage Heart Failure
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT01045343 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 136 participants.
The verdict
NCT01045343, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the potential benefits of a new heart failure diagnostic system for heart failure patients with implanted cardiac resynchronization therapy devices. This system consists of patient tools, a new heart failure risk score and a new clinician website. This study will evaluate this new system as a whole and establish the feasibility of implementing it into clinical practice.
Interventions
- OTHER Integrated diagnositic system
- OTHER Routine in office visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01045343
The ClinicalTrials.gov registry entry for NCT01045343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Integrated diagnositic system is the first listed.
NCT01045343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01045343 about?
NCT01045343 is a clinical study titled "Feasibility Study of an Integrated Diagnostic System to Manage Heart Failure". The purpose of this clinical trial is to evaluate the potential benefits of a new heart failure diagnostic system for heart failure patients with implanted cardiac resynchronization therapy devices. This system consists of patient tools, a new heart failure risk score and a new clinician website. Th...
What is the current status of trial NCT01045343?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2010-03. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01045343?
The interventions under investigation include: Integrated diagnositic system (OTHER), Routine in office visits (OTHER).
Who is sponsoring clinical trial NCT01045343?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.